Avita Medical | 1811094D - Equity Capital And Reserves



Avita Medical reported AUD4.5M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Adcock Ingram Holdings ZAR 5.54B 131.19M Dec/2024
Celltrion KRW 17.14T 298.25B Mar/2025
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Cochlear AUD 1.87B 27.1M Dec/2024
CSL USD 20.55B 3.18B Dec/2024
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Divis Laboratories Ltd 149.69B 12.52B Mar/2025
Kangmei Pharma CNY 7.73B 546.26M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 574.72M 6.82M Jun/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Medical Developments International AUD 55.33M 9.6M Dec/2024
Nanosonics AUD 189.03M 6.82M Dec/2024
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Organigram Holdings CAD 385.5M 61.85M Jun/2025
Pacific Edge NZD 26.08M 14.57M Mar/2025
Paradigm Biopharmaceuticals AUD 34.06M 10.25M Dec/2024
Pharma Mar EUR 201.53M 4.06M Jun/2025
Polynovo AUD 72.12M 3.07M Jun/2024
PYC Therapeutics AUD 55.44M 25.62M Dec/2024
Qiagen NV USD 3.51B 97.61M Jun/2025
Ramsay Health Care AUD 4.81B 82.9M Dec/2024
ResMed USD 5.97B 714.85M Jun/2025
Sartorius EUR 2.66B 51.3M Jun/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024
Tilray USD 3.47B 5.16M Nov/2024
Zz Pientze Pharmaceu 14.65B 617.48M Jun/2025